WebOct 2, 2024 · AstraZeneca’s Farxiga (dapagliflozin) has been granted Breakthrough Therapy Designation (BTD) in the US for patients with chronic kidney disease (CKD), with and without type-2 diabetes (T2D).. CKD is a serious, progressive condition defined by decreased kidney function and is often associated with an increased risk of heart … Thirty years ago, the American immunologist Jim Allison led research efforts that revealed the existence of immune checkpoints. Specifically, he and colleagues found that a protein on the surface of immune system T cells acts as a checkpoint, or brake, to prevent an overzealous immune system response. Allison’s … See more A major theme in cancer research—and not just for kidney cancers—is the recognition that the disease is highly variable. Voss says that kidney cancer comes in different “flavors,” or molecular subtypes, that help … See more There’s a lot more going on in kidney cancer care. McDermott says another promising advancement involves a class of drug known as hypoxia inducible factor (HIF)-2α inhibitors. … See more

Innovative technique developed to destroy cancerous kidney cells

Web4 hours ago · More than 50% of all deaths across the globe are linked to chronic inflammation-related diseases such as ischemic heart disease, cancer, stroke, diabetes mellitus, kidney disease, non-alcoholic ... WebApr 15, 2024 · A new treatment for people with diabetes and kidney disease reduced kidney failure rates by a third, according to a landmark trial. ... Breakthrough kidney disease treatment offers hope for ... eaw 730p

Amyloidosis - Diagnosis and treatment - Mayo Clinic

WebOct 18, 2024 · Although it is manageable moderately through medicine and lifestyle changes, CKD is also one such condition that stands to benefit greatly from breakthroughs in treatment. Finding new ways to manage kidney disease, prevent deterioration of the kidneys, and minimise the possibility of kidney failure are key areas of research. … WebResearch continues on other foods and drugs to see their affect on delaying kidney failure, including: fish oil for IgA nephropathy; dietary intake of antioxidant or anti-inflammatory vitamins and foods; and prescribing the anti-fibrotic drug, pirfenidone, for the treatment of focal segmental glomerulosclerosis (FSGS). Web4 hours ago · More than 50% of all deaths across the globe are linked to chronic inflammation-related diseases such as ischemic heart disease, cancer, stroke, diabetes … eaw 325